58 related articles for article (PubMed ID: 24274763)
21. Microarray studies of factor VIIa-activated cancer cells.
Petersen LC
Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
[TBL] [Abstract][Full Text] [Related]
23. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
24. 2D-DIGE: comparative proteomics of cellular signalling pathways.
Larbi NB; Jefferies C
Methods Mol Biol; 2009; 517():105-32. PubMed ID: 19378013
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.
Chen J; Bierhaus A; Schiekofer S; Andrassy M; Chen B; Stern DM; Nawroth PP
Thromb Haemost; 2001 Jul; 86(1):334-45. PubMed ID: 11487022
[TBL] [Abstract][Full Text] [Related]
26. Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system.
Gu D; Huang J; Shan Z; Yin Y; Zheng S; Wu P
Int J Urol; 2013 Oct; 20(10):1024-31. PubMed ID: 23379290
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
28. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.
Yan G; Li L; Tao Y; Liu S; Liu Y; Luo W; Wu Y; Tang M; Dong Z; Cao Y
Proteomics; 2006 Mar; 6(6):1810-21. PubMed ID: 16470631
[TBL] [Abstract][Full Text] [Related]
30. Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release.
Langer F; Morys-Wortmann C; Küsters B; Storck J
Br J Haematol; 1999 May; 105(2):542-50. PubMed ID: 10233435
[TBL] [Abstract][Full Text] [Related]
31. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
32. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin.
Saeki K; Yasugi E; Okuma E; Breit SN; Nakamura M; Toda T; Kaburagi Y; Yuo A
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E419-28. PubMed ID: 15827065
[TBL] [Abstract][Full Text] [Related]
34. The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells.
Madkhali Y; Featherby S; Collier ME; Maraveyas A; Greenman J; Ettelaie C
TH Open; 2019 Apr; 3(2):e132-e145. PubMed ID: 31259295
[TBL] [Abstract][Full Text] [Related]
35. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel downstream molecules of tissue factor activation by comparative proteomic analysis.
Kask L; Jorsback A; Winkvist M; Alfredsson J; Ek B; Bergquist J; Siegbahn A
J Proteome Res; 2014 Feb; 13(2):477-88. PubMed ID: 24274763
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
38. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Sørensen BB; Rao LV
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
[TBL] [Abstract][Full Text] [Related]
39. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
40. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
